MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Levodopa/carbidopa intestinal gel treatment in advanced Parkinson’s disease: A long-term observational study

    P. Havránková, J. Klempír, M. Fialová, A. Rezková, J. Petrtýl, V. Capek, E. Ruzicka, J. Roth, R. Jech (Praha, Czech Republic)

    Objective: To evaluate long-term efficacy, levodopa dose changes and complications in patients with advanced Parkinson's disease (PD) treated. Background: Administrated via percutaneous gastric gastrostomy to…
  • 2016 International Congress

    Effect of patient characteristics on motor function in response to 35–50 mg of inhaled levodopa (CVT-301) in patients with Parkinson’s disease: Results from a phase 2b study

    P.A. LeWitt, M.I. Freed, M. Leinonen, A. Sedkov, H. Murck (West Bloomfield, MI, USA)

    Objective: To examine whether the response to an inhaled levodopa formulation (CVT-301; at 35 and 50 mg per dose) is dependent on baseline patient characteristics.…
  • 2016 International Congress

    Improved motor functioning of people with Parkinson’s disease following dance intervention

    S.M. Simone, K.A. Beben, S.E. Maguire, C. Noudga, K.L.M. Martin, G.N. Luabeya, P. Dhami, R.J. Bar, J.F. DeSouza (Toronto, ON, Canada)

    Objective: To investigate the effectiveness of dance as an additional treatment for people with Parkinson's disease (PD). Background: Common pharmacological treatments for PD lessen the…
  • 2016 International Congress

    Objective measures of Parkinsonian motor symptoms using a continuously worn smartwatch

    N. Fixler, L. Reitblat, A. Wagner, S. Cohen, M. Afek, P. Bonato, J.F. Daneault, N. Golabchi, S. Moore, A. Patel, C. Cho, L. Bataille (Petach Tikva, Israel)

    Objective: To determine whether smartwatch sensor data correlates with clinician-measured Parkinson's disease symptoms. Background: Data collected with smartwatches could be used for long-term, continuous assessment…
  • 2016 International Congress

    Safety and tolerability of inhaled levodopa (CVT-301) administered to Parkinson’s disease patients with motor fluctuations

    R. Pahwa, P. LeWitt, A. Corbin, R. Batycky, H. Murck (Kansas City, KS, USA)

    Objective: Two Phase 2 studies were conducted to evaluate the safety profile of inhaled CVT-301 administered to Parkinson's disease (PD) patients with motor fluctuations. Background:…
  • 2016 International Congress

    Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle

    P. Tanvijit, A.P. Moore (Bangkok, Thailand)

    Objective: To explore 1) relationship between peak benefit and Duration of Adequate Response (DAR) after BoNT, 2) frequency & causes of secondary Treatment Failure (TF),…
  • 2016 International Congress

    Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis

    A. Pal, B.R. Thapa, R.K. Vasishta, R. Prasad (Chandigarh, India)

    Objective: To evaluate the copper (Cu) chelation efficacy of orally administered D-penicillamine loaded nanoparticles to that of conventional D-penicillamine therapy for 90 days in Wistar…
  • 2016 International Congress

    A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease

    C.C. Walton, L. Mowszowski, J.M. Shine, M. Gilat, J.M. Hall, C. O'Callaghan, A.J. Muller, M. Georiades, J.Y.Y. Szeto, K.A. Ehgoetz Martens, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

    Objective: To investigate the potential of cognitive training to improve symptoms of freezing of gait in Parkinson's disease. Background: Freezing of gait (FOG) is a…
  • 2016 International Congress

    Lead angle matters: Side effects of deep brain stimulation improved with adjustment of lead angle

    M.H. Pourfar, A.Y. Mogilner (New York, NY, USA)

    Objective: A variety of technical considerations influence the outcome of Deep Brain Stimulation (DBS). We highlight a case where revising the angle of approach significantly…
  • 2016 International Congress

    Non-motor outcomes of subthalamic stimulation in Parkinson’s disease depend on the location of active contacts

    H.S. Dafsari, J.N. Petry-Schmelzer, K. Ashkan, L. Weis, T. Dembek, M. Samuel, A. Rizos, M. Silverdale, J. Evans, P. Martinez-Martin, A. Antonini, K.R. Chaudhuri, V. Visser-Vandewalle, L. Timmermann (Cologne, Germany)

    Objective: To investigate the impact of active electrode contact location on non-motor outcomes in patients with Parkinson's disease (PD) and subthalamic nucleus (STN) deep brain…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley